IMMURON LTD-SPON ADR (IMRN) Stock Price, Forecast & Analysis
NASDAQ:IMRN • US45254U1016
IMRN Key Statistics, Chart & Performance
The current stock price of IMRN is 0.77 USD. In the past month the price decreased by -15.53%. In the past year, price decreased by -59.47%.
IMRN Technical Analysis
IMRN Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to IMRN. The financial health of IMRN is average, but there are quite some concerns on its profitability.
IMRN Financial Highlights
Over the last trailing twelve months IMRN reported a non-GAAP Earnings per Share(EPS) of -0.46. The EPS increased by 25.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -51.49% | ||
| ROE | -64.64% | ||
| Debt/Equity | 0 |
IMRN Forecast & Estimates
IMRN Ownership
IMRN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.98 | 410.174B | ||
| AMGN | AMGEN INC | 17.23 | 209.016B | ||
| GILD | GILEAD SCIENCES INC | 16.7 | 184.799B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.37 | 126.056B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.83 | 82.638B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 49.7 | 43.982B | ||
| INSM | INSMED INC | N/A | 31.848B | ||
| NTRA | NATERA INC | N/A | 28.947B | ||
| BIIB | BIOGEN INC | 12.61 | 28.152B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.1 | 21.698B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About IMRN
Company Profile
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.
Company Info
IMMURON LTD-SPON ADR
62 Lygon Street, Level 3
Melbourne VICTORIA 3053 AU
CEO: Jerry Kanellos
Employees: 7
Phone: 61398245254
IMMURON LTD-SPON ADR / IMRN FAQ
What does IMRN do?
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.
What is the current price of IMRN stock?
The current stock price of IMRN is 0.77 USD. The price decreased by -8.3% in the last trading session.
What is the dividend status of IMMURON LTD-SPON ADR?
IMRN does not pay a dividend.
How is the ChartMill rating for IMMURON LTD-SPON ADR?
IMRN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is IMMURON LTD-SPON ADR worth?
IMMURON LTD-SPON ADR (IMRN) has a market capitalization of 6.22M USD. This makes IMRN a Nano Cap stock.